The object of this Alert is to highlight some practical implications of Brexit for the supply of pharmaceutical products and medical devices in the European Union (EU) and related action items which companies should be...more
4/6/2018
/ EU ,
EU Single Market ,
European Economic Area (EEA) ,
European Medicines Agency (EMA) ,
Free Trade Agreements ,
Marketing Authorization Application ,
Medical Devices ,
Pharmaceutical Industry ,
Supply Chain ,
UK ,
UK Brexit